The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117198659 11719865 9 F 201509 20160802 20151110 20160807 EXP CA-ROCHE-1489504 ROCHE 64.30 YR F Y 0.00000 20160808 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117198659 11719865 1 PS RITUXAN RITUXIMAB 1 Intravenous (not otherwise specified) DATE OF LAST RITUXIMAB INFUSION 11/JUN/2015 H3701B02,N3708B01 103705 1000 MG SOLUTION FOR INFUSION
117198659 11719865 2 SS RITUXAN RITUXIMAB 1 Intravenous (not otherwise specified) H3701B02,N3708B01 103705 500 MG SOLUTION FOR INFUSION
117198659 11719865 3 SS RITUXAN RITUXIMAB 1 Intravenous (not otherwise specified) H3701B02,N3708B01 103705 1000 MG SOLUTION FOR INFUSION
117198659 11719865 4 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 736 MG SOLUTION FOR INFUSION
117198659 11719865 5 C ACETAMINOPHEN. ACETAMINOPHEN 1 Oral 0 650 MG
117198659 11719865 6 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Intravenous (not otherwise specified) 0 100 MG
117198659 11719865 7 C PREDNISONE. PREDNISONE 1 0
117198659 11719865 8 C DURAGESIC (CANADA) 2 0
117198659 11719865 9 C MYFORTIC MYCOPHENOLATE SODIUM 1 0
117198659 11719865 10 C CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 Unknown 0
117198659 11719865 11 C DIPHENHYDRAMINE. DIPHENHYDRAMINE 1 Oral 0 50 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117198659 11719865 1 Rheumatoid arthritis
117198659 11719865 4 Rheumatoid arthritis
117198659 11719865 5 Premedication
117198659 11719865 6 Premedication

Outcome of event

Event ID CASEID OUTC COD
117198659 11719865 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
117198659 11719865 Activities of daily living impaired
117198659 11719865 Blood disorder
117198659 11719865 Blood pressure fluctuation
117198659 11719865 Body temperature decreased
117198659 11719865 Burning sensation
117198659 11719865 Cough
117198659 11719865 Crepitations
117198659 11719865 Drug ineffective
117198659 11719865 Dyspnoea
117198659 11719865 Emphysema
117198659 11719865 Erythema
117198659 11719865 Fatigue
117198659 11719865 Fear
117198659 11719865 Injection site extravasation
117198659 11719865 Lung abscess
117198659 11719865 Oropharyngeal pain
117198659 11719865 Oxygen saturation decreased
117198659 11719865 Pain
117198659 11719865 Pleural effusion
117198659 11719865 Pneumonia
117198659 11719865 Urinary tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
117198659 11719865 1 20141105 0
117198659 11719865 2 20151217 0
117198659 11719865 3 20160107 20160107 0
117198659 11719865 4 20160725 0
117198659 11719865 5 20141105 0
117198659 11719865 6 20141105 0
117198659 11719865 11 20141105 0